SlideServe
Menu
Préférences
© SlideServe · v2026

Anemia

parley avatar
24 diapositives · 1.1K Views · Jul 18, 2014

Anemia. Dr. Meg- angela Christi M. Amores. What is Hematopoeisis ?. It is the process by which the formed elements of the blood are produced Erythropoeisis : production of erythrocytes (red blood cells) Regulatory hormone: EPO ( erythropoeitin ) kidney. Erythropoeisis.

Anemia - slide 1
01 / 24Anemia
1 / 17

Télécharger la présentation

Anemia
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation
  1. Anemia Dr. Meg-angela Christi M. Amores

  2. What is Hematopoeisis? • It is the process by which the formed elements of the blood are produced • Erythropoeisis: production of erythrocytes (red blood cells) • Regulatory hormone: EPO (erythropoeitin) • kidney

  3. Erythropoeisis • Critical elements: • EPO production • iron availability • the proliferative capacity of the bone marrow • effective maturation of red cell precursors

  4. Anemia • Often recognized by abnormal screening tests • Less commonly presents signs and symptoms unless advanced • Acute anemia – due to blood loss or hemolysis • If acute blood loss, hypovolemia results • Hypotension is the issue, not anemia • 10 – 15% blood loss- signs of vascular instability • >30% - postural hypotension, tachycardia • >40% - hypovolemic shock (confusion, dyspnea, diaphoresis, hypotension, tachycardia)

  5. Anemia • Acute anemia – due to blood loss or hemolysis • Acute hemolysis • Symptoms: fatigue, loss of stamina, breathlessness, and tachycardia (particularly with physical exertion) • Most often only occurs when advanced (hgb <7 mg/dL)

  6. Approach to patient • History: • Nutritional (food, drugs, alcohol) • Family history • G6PD deficiency • PE: • Findings of infection • blood in the stool, lymphadenopathy, splenomegaly, or petechiae • forceful heartbeat, strong peripheral pulses, and a systolic "flow" murmur

  7. Pallor • skin and mucous membranes may be pale if the hemoglobin is <80–100 g/L (8–10 g/dL) • If palmar creases are lighter in color than the surrounding skin when the hand is hyperextended, the hemoglobin level is usually <80 g/L (8 g/dL)

  8. Laboratory Evaluation

  9. Normal Hgb and Hct levels

  10. CBC • Components of CBC help in the classification of anemia: • Microcytosis - reflected by a lower than normal MCV (<80) • Macrocytosis - high values (>100) of MCV • MCH and MCHC reflect defects in hemoglobin synthesis - hypochromia

  11. Peripheral blood smear • provides important information about defects in red cell production • the blood smear also reveals variations in cell size (anisocytosis) and shape (poikilocytosis)

  12. Reticulocyte count • key to the initial classification of anemia • Normally, the reticulocyte count ranges from 1–2% and reflects the daily replacement of 0.8–1.0% of the circulating red cell population • reticulocyte count provides a reliable measure of red cell production • In the face of established anemia, a reticulocyte response less than two to three times normal indicates an inadequate marrow response.

  13. Tests of Iron Supply and storage • serum iron • TIBC • percent transferrin saturation • serum ferritin is used to evaluate total-body iron stores

  14. Bone Marrow examination • Indications: • patients with hypoproliferativeanemia and normal iron status • can diagnose primary marrow disorders such as myelofibrosis, a red cell maturation defect, or an infiltrative disease

  15. Functional Classification • marrow production defects (hypoproliferation) • red cell maturation defects (ineffective erythropoiesis) • decreased red cell survival (blood loss /hemolysis)

  16. HypoproliferativeAnemia • 75% of all anemia • reflects absolute or relative marrow failure • Majority are due to mild to moderate iron deficiency or inflammation • can result from marrow damage, iron deficiency, or inadequate EPO stimulation • normocytic, normochromic red cells • Key diagnostic tool: IRON studies

  17. HypoproliferativeAnemia • anemia of acute or chronic inflammation • serum iron (low), TIBC (normal or low), percent transferrin saturation (low), and serum ferritin (normal or high) • mild to moderate iron deficiency • (low serum iron, high TIBC, low percent transferrin saturation, low serum ferritin)

  18. Maturation disorders • anemia with an inappropriately low reticulocyte production index, macro- or microcytosis on smear, and abnormal red cell indices • ineffective erythropoiesis that results from the destruction within the marrow • vitamin B12 or folic acid deficiency, drug damage, or myelodysplasia

  19. Blood Loss / HemolyticAnemia • Red blood cell indices >2.5x the normal • stimulated erythropoiesis • typically normocytic or slightly macrocytic • Hemolysis – least common form of anemia • present in different ways • paroxysmal nocturnal hemoglobinuria • Hemoglobinopathies • hereditary spherocytosis

  20. Treatment • Severe anemia: red cell transfusions • acute or gradual onset: determined by the documented cause(s) of the anemia • important to evaluate the patient's iron status fully • Chronic kidney disease: Recombinant EPO